News-Medical.Net November 4, 2024
Alimetry

Alimetry has raised an oversubscribed US $18m A2 financing round to commercialize its wearable gut health monitoring device, capitalizing on increased adoption by a growing cohort of US hospitals. This adoption is driven by Alimetry receiving its fourth FDA clearance, the establishment of a CPT III reimbursement code, and the completion of over 30 clinical studies. Alimetry’s flagship AI powered product delivers accurate analysis and diagnosis of gut disorders that have been proven difficult to solve using conventional diagnostics and testing. The oversubscribed round was led by GD1 (Global from Day One), with participation from the American Gastroenterological Association (AGA) GI Opportunity Fund, Olympus Innovation Ventures, IceHouse Ventures, and follow on from existing investors. ​​​​​​​

Nearly one in 10 people...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Technology, Trends, Wearables
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure
Oura Ring Major Update To Integrate Key Feature: Blood Sugar Monitoring
The AirPods Pro’s Game-Changing Health Feature, Explained By Apple Execs
Validic Integrates Glucose Monitoring Data Directly Into EHR Clinical Workflows

Share This Article